Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Localised Cancer

NCT05533515 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT05533515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05533515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Localised Cancer
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Completed
Start date
February 8, 2022
Completion date
March 5, 2024
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer